Zosano Pharma to Present at the Cantor Virtual Global Healthcare Conference
September 09 2020 - 8:30AM
Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage
biopharmaceutical company, today announced that its president and
chief executive officer, Steven Lo, will present a company overview
at the Cantor Virtual Global Healthcare Conference on Tuesday,
September 15, 2020 at 10:40 am ET.
A live webcast of the event will be available on the company’s
website at http://ir.zosanopharma.com/events-presentations. The
archived webcast will remain available for 30 days following the
date of the presentation.
About Zosano PharmaZosano Pharma Corporation is
a clinical-stage biopharmaceutical company focused on developing
products where rapid administration of approved molecules with
established safety and efficacy profiles may provide substantial
benefit to patients, in markets where patients remain underserved
by existing therapies. The company’s transdermal microneedle system
technology consists of titanium microneedles coated with drug that
are designed to enable rapid systemic administration of
therapeutics to patients. Zosano’s lead product candidate is
Qtrypta™ (M207), which is a proprietary formulation of zolmitriptan
delivered via its transdermal microneedle system technology, as an
acute treatment for migraine. The company anticipates that many of
its current and future development programs may enable the company
to utilize a regulatory pathway that has the potential to
streamline clinical development and accelerate the path towards
commercialization. Learn more at www.zosanopharma.com.
Zosano Contact:Christine MatthewsChief
Financial Officer 510-745-1200
PR Contacts:Sylvia Wheeler or Alexandra
Santosswheeler@wheelhouselsa.com or asantos@wheelhouselsa.com
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Sep 2023 to Sep 2024